QUEST DIAGNOSTICS

Trade DGX
Earnings expected on 2025-07-22 in the pre market. Expected move: ∞% (+/- $9.78)
DGX Insider Trades:
all
Powered by unusualwhales.com
Ticker
Trade Date
Filing Date
Name
Title
Code
Security
Amount
Price
Value
Trans.
10b5-1
Director
10% Owner
Mcap/AUM
2025-07-01
2025-07-02
LASSITER WRIGHT III
A - Grant
Phantom Stock Units
160
$0.00
1
$20.07B
2025-07-01
2025-07-02
RING TIMOTHY
A - Grant
Phantom Stock Units
236
$0.00
1
$20.07B
2025-05-15
2025-05-19
RING TIMOTHY
A - Grant
Common Stock
1,203
$0.00
1
$20.07B
2025-05-15
2025-05-19
PFEIFFER GARY
A - Grant
Common Stock
1,203
$0.00
1
$20.07B
2025-05-15
2025-05-19
MORRISON DENISE
A - Grant
Common Stock
1,203
$0.00
1
$20.07B
2025-05-15
2025-05-19
MAIN TIMOTHY
A - Grant
Common Stock
1,203
$0.00
1
$20.07B
2025-05-15
2025-05-19
DOI TRACEY
A - Grant
Common Stock
1,203
$0.00
1
$20.07B
2025-05-15
2025-05-19
DIAZ LUIS
A - Grant
Common Stock
1,203
$0.00
1
$20.07B
2025-05-15
2025-05-19
CARTER ROBERT
A - Grant
Common Stock
1,203
$0.00
1
$20.07B
2025-05-15
2025-05-19
GREGG VICKY
A - Grant
Common Stock
1,203
$0.00
1
$20.07B
2025-05-15
2025-05-19
LASSITER WRIGHT III
A - Grant
Common Stock
1,203
$0.00
1
$20.07B
2025-05-13
2025-05-14
DELANEY MARK
SVP & Chief Commercial Officer
S - Sale
Common Stock
-874
$175.00
-153K
1
$20.07B
2025-05-12
2025-05-14
DELANEY MARK
SVP & Chief Commercial Officer
S - Sale
Common Stock
-874
$176.00
-154K
1
$20.07B
2025-04-21
2025-05-02
SAMAD SAM
Executive Vice President & CFO
L - Small Acquisition
Common Stock
74
$164.00
12,136
1
$20.07B
2025-04-21
2025-05-02
GREGG VICKY
A - Grant
Common Stock
68
$164.00
11,152
1
$20.07B
2025-04-21
2025-05-02
DELANEY MARK
SVP & Chief Commercial Officer
L - Small Acquisition
Common Stock
25
$164.00
4,100
1
$20.07B
2025-04-21
2025-05-02
KUPPUSAMY KARTHIK
SVP, Clinical Solutions
L - Small Acquisition
Common Stock
27
$164.00
4,428
1
$20.07B
2025-04-21
2025-05-02
PLEWMAN PATRICK
SVP for Diagnostic Services
L - Small Acquisition
Common Stock
81
$164.00
13,284
1
$20.07B
2025-04-02
2025-04-04
KUPPUSAMY KARTHIK
SVP, Clinical Solutions
S - Sale
Common Stock
-2,555
$170.00
-434K
1
$20.07B
2025-04-02
2025-04-04
DAVIS
CEO and President
S - Sale
Common Stock
-39,191
$168.00
-6.58M
15
$20.07B
2025-04-01
2025-04-03
LASSITER WRIGHT III
A - Grant
Phantom Stock Units
169
$0.00
1
$20.07B
2025-04-01
2025-04-03
RING TIMOTHY
A - Grant
Phantom Stock Units
251
$0.00
1
$20.07B
2025-03-26
2025-03-28
DELANEY MARK
SVP & Chief Commercial Officer
F - Tax
Common Stock
-256
$167.00
-42,752
1
$20.07B
2025-03-26
2025-03-28
PLEWMAN PATRICK
SVP for Diagnostic Services
F - Tax
Common Stock
-162
$167.00
-27,054
1
$20.07B
2025-03-17
2025-03-19
PREVOZNIK MICHAEL
SVP & General Counsel
S - Sale
Common Stock
-4,643
$170.00
-789K
1
$20.07B
2025-03-05
2025-03-07
DOHERTY CATHERINE
EVP, Regional Businesses
S - Sale
Common Stock
-5,370
$174.00
-934K
1
$20.07B
2025-03-04
2025-03-05
PLEWMAN PATRICK
SVP for Diagnostic Services
A - Grant
Common Stock
5,674
$174.00
987K
1
$20.07B
2025-03-04
2025-03-05
PREVOZNIK MICHAEL
SVP & General Counsel
A - Grant
Common Stock
8,549
$174.00
1.49M
1
$20.07B
2025-03-04
2025-03-05
SAMAD SAM
Executive Vice President & CFO
A - Grant
Common Stock
13,884
$174.00
2.42M
1
$20.07B
2025-03-04
2025-03-05
DAVIS
CEO and President
F - Tax
Common Stock
-31,656
$174.00
-5.51M
1
$20.07B
2025-03-04
2025-03-05
DELANEY MARK
SVP & Chief Commercial Officer
F - Tax
Common Stock
-1,823
$174.00
-317K
1
$20.07B
2025-03-04
2025-03-05
DEPPE MICHAEL
SVP, Corp. Controller & CAO
F - Tax
Common Stock
-867
$174.00
-151K
1
$20.07B
2025-03-04
2025-03-05
DOHERTY CATHERINE
EVP, Regional Businesses
F - Tax
Common Stock
-5,010
$174.00
-872K
1
$20.07B
2025-03-04
2025-03-05
KUPPUSAMY KARTHIK
SVP, Clinical Solutions
F - Tax
Common Stock
-1,879
$174.00
-327K
1
$20.07B
2025-03-04
2025-03-05
PLEWMAN PATRICK
SVP for Diagnostic Services
F - Tax
Common Stock
-2,280
$174.00
-397K
1
$20.07B
2025-03-04
2025-03-05
PREVOZNIK MICHAEL
SVP & General Counsel
F - Tax
Common Stock
-3,906
$174.00
-680K
1
$20.07B
2025-03-04
2025-03-05
SAMAD SAM
Executive Vice President & CFO
F - Tax
Common Stock
-7,684
$174.00
-1.34M
1
$20.07B
2025-03-04
2025-03-05
DAVIS
CEO and President
A - Grant
Common Stock
61,917
$174.00
11M
1
$20.07B
2025-03-04
2025-03-05
DOHERTY CATHERINE
EVP, Regional Businesses
S - Sale
Common Stock
-716
$176.00
-126K
1
$20.07B
2025-03-04
2025-03-05
PREVOZNIK MICHAEL
SVP & General Counsel
S - Sale
Common Stock
-592
$176.00
-104K
1
$20.07B
2025-03-04
2025-03-05
DOHERTY CATHERINE
EVP, Regional Businesses
S - Sale
Common Stock
-716
$176.00
-126K
1
$20.07B
2025-03-04
2025-03-05
PREVOZNIK MICHAEL
SVP & General Counsel
S - Sale
Common Stock
-592
$176.00
-104K
1
$20.07B
2025-03-04
2025-03-05
DAVIS
CEO and President
A - Grant
Common Stock
61,917
$174.00
11M
1
$20.07B
2025-03-04
2025-03-05
DELANEY MARK
SVP & Chief Commercial Officer
A - Grant
Common Stock
5,317
$174.00
925K
1
$20.07B
2025-03-04
2025-03-05
DEPPE MICHAEL
SVP, Corp. Controller & CAO
A - Grant
Common Stock
1,711
$174.00
298K
1
$20.07B
2025-03-04
2025-03-05
DOHERTY CATHERINE
EVP, Regional Businesses
A - Grant
Common Stock
10,380
$174.00
1.81M
1
$20.07B
2025-03-04
2025-03-05
KUPPUSAMY KARTHIK
SVP, Clinical Solutions
A - Grant
Common Stock
4,434
$174.00
772K
1
$20.07B
2025-03-04
2025-03-05
PLEWMAN PATRICK
SVP for Diagnostic Services
A - Grant
Common Stock
5,674
$174.00
987K
1
$20.07B
2025-03-04
2025-03-05
PREVOZNIK MICHAEL
SVP & General Counsel
A - Grant
Common Stock
8,549
$174.00
1.49M
1
$20.07B
2025-03-04
2025-03-05
SAMAD SAM
Executive Vice President & CFO
A - Grant
Common Stock
13,884
$174.00
2.42M
1
$20.07B
2025-03-04
2025-03-05
DAVIS
CEO and President
F - Tax
Common Stock
-31,656
$174.00
-5.51M
1
$20.07B
2025-03-04
2025-03-05
DELANEY MARK
SVP & Chief Commercial Officer
F - Tax
Common Stock
-1,823
$174.00
-317K
1
$20.07B
2025-03-04
2025-03-05
DEPPE MICHAEL
SVP, Corp. Controller & CAO
F - Tax
Common Stock
-867
$174.00
-151K
1
$20.07B
2025-03-04
2025-03-05
DOHERTY CATHERINE
EVP, Regional Businesses
F - Tax
Common Stock
-5,010
$174.00
-872K
1
$20.07B
2025-03-04
2025-03-05
KUPPUSAMY KARTHIK
SVP, Clinical Solutions
F - Tax
Common Stock
-1,879
$174.00
-327K
1
$20.07B
2025-03-04
2025-03-05
PLEWMAN PATRICK
SVP for Diagnostic Services
F - Tax
Common Stock
-2,280
$174.00
-397K
1
$20.07B
2025-03-04
2025-03-05
PREVOZNIK MICHAEL
SVP & General Counsel
F - Tax
Common Stock
-3,906
$174.00
-680K
1
$20.07B
2025-03-04
2025-03-05
SAMAD SAM
Executive Vice President & CFO
F - Tax
Common Stock
-7,684
$174.00
-1.34M
1
$20.07B
2025-03-04
2025-03-05
DELANEY MARK
SVP & Chief Commercial Officer
A - Grant
Common Stock
5,317
$174.00
925K
1
$20.07B
2025-03-04
2025-03-05
DEPPE MICHAEL
SVP, Corp. Controller & CAO
A - Grant
Common Stock
1,711
$174.00
298K
1
$20.07B
2025-03-04
2025-03-05
DOHERTY CATHERINE
EVP, Regional Businesses
A - Grant
Common Stock
10,380
$174.00
1.81M
1
$20.07B
2025-03-04
2025-03-05
KUPPUSAMY KARTHIK
SVP, Clinical Solutions
A - Grant
Common Stock
4,434
$174.00
772K
1
$20.07B
2025-03-03
2025-03-05
DAVIS
CEO and President
F - Tax
Common Stock
-1,662
$174.00
-289K
1
$20.07B
2025-03-03
2025-03-05
DEPPE MICHAEL
SVP, Corp. Controller & CAO
F - Tax
Common Stock
-1,692
$174.00
-294K
1
$20.07B
2025-03-03
2025-03-05
DOHERTY CATHERINE
EVP, Regional Businesses
F - Tax
Common Stock
-394
$174.00
-68,556
1
$20.07B
2025-03-03
2025-03-05
KUPPUSAMY KARTHIK
SVP, Clinical Solutions
F - Tax
Common Stock
-992
$174.00
-173K
1
$20.07B
2025-03-03
2025-03-05
PLEWMAN PATRICK
SVP for Diagnostic Services
F - Tax
Common Stock
-106
$174.00
-18,444
1
$20.07B
2025-03-03
2025-03-05
PREVOZNIK MICHAEL
SVP & General Counsel
F - Tax
Common Stock
-322
$174.00
-56,028
1
$20.07B
2025-02-27
2025-02-28
DOHERTY CATHERINE
EVP, Regional Businesses
S - Sale
Common Stock
-824
$173.00
-143K
1
$20.07B
2025-02-27
2025-02-28
PREVOZNIK MICHAEL
SVP & General Counsel
S - Sale
Common Stock
-528
$173.00
-91,344
1
$20.07B
2025-02-26
2025-02-28
DAVIS
CEO and President
F - Tax
Common Stock
-2,966
$172.00
-510K
1
$20.07B
2025-02-26
2025-02-28
PREVOZNIK MICHAEL
SVP & General Counsel
F - Tax
Common Stock
-286
$172.00
-49,192
1
$20.07B
2025-02-26
2025-02-28
SAMAD SAM
Executive Vice President & CFO
F - Tax
Common Stock
-869
$172.00
-149K
1
$20.07B
2025-02-26
2025-02-28
DELANEY MARK
SVP & Chief Commercial Officer
F - Tax
Common Stock
-214
$172.00
-36,808
1
$20.07B
2025-02-26
2025-02-28
DEPPE MICHAEL
SVP, Corp. Controller & CAO
F - Tax
Common Stock
-88
$172.00
-15,136
1
$20.07B
2025-02-26
2025-02-28
DOHERTY CATHERINE
EVP, Regional Businesses
F - Tax
Common Stock
-455
$172.00
-78,260
1
$20.07B
2025-02-26
2025-02-28
KUPPUSAMY KARTHIK
SVP, Clinical Solutions
F - Tax
Common Stock
-233
$172.00
-40,076
1
$20.07B
2025-02-26
2025-02-28
PLEWMAN PATRICK
SVP for Diagnostic Services
F - Tax
Common Stock
-229
$172.00
-39,388
1
$20.07B
2025-02-20
2025-02-21
DOHERTY CATHERINE
EVP, Regional Businesses
S - Sale
Common Stock
-899
$171.00
-154K
1
$20.07B
2025-02-20
2025-02-21
PREVOZNIK MICHAEL
SVP & General Counsel
S - Sale
Common Stock
-604
$171.00
-103K
1
$20.07B
2025-02-19
2025-02-21
SAMAD SAM
Executive Vice President & CFO
F - Tax
Common Stock
-1,031
$170.00
-175K
1
$20.07B
2025-02-19
2025-02-21
PLEWMAN PATRICK
SVP for Diagnostic Services
S - Sale
Common Stock
-320
$170.00
-54,400
1
$20.07B
2025-02-19
2025-02-21
DOHERTY CATHERINE
EVP, Regional Businesses
S - Sale
Common Stock
-535
$170.00
-90,950
1
$20.07B
2025-02-19
2025-02-21
DAVIS
CEO and President
F - Tax
Common Stock
-2,936
$170.00
-499K
1
$20.07B
2025-02-19
2025-02-21
DELANEY MARK
SVP & Chief Commercial Officer
F - Tax
Common Stock
-242
$170.00
-41,140
1
$20.07B
2025-02-19
2025-02-21
KUPPUSAMY KARTHIK
SVP, Clinical Solutions
F - Tax
Common Stock
-287
$170.00
-48,790
1
$20.07B
2025-02-19
2025-02-21
DEPPE MICHAEL
SVP, Corp. Controller & CAO
F - Tax
Common Stock
-99
$170.00
-16,830
1
$20.07B
2025-02-19
2025-02-21
PREVOZNIK MICHAEL
SVP & General Counsel
F - Tax
Common Stock
-374
$170.00
-63,580
1
$20.07B
2025-02-12
2025-02-14
PLEWMAN PATRICK
SVP for Diagnostic Services
A - Grant
Non-Qualifed Stock Option (right to buy)
7,833
$0.00
1
$20.07B
2025-02-12
2025-02-14
PLEWMAN PATRICK
SVP for Diagnostic Services
A - Grant
Common Stock
2,042
$0.00
1
$20.07B
2025-02-12
2025-02-14
PREVOZNIK MICHAEL
SVP & General Counsel
A - Grant
Non-Qualifed Stock Option (right to buy)
8,991
$0.00
1
$20.07B
2025-02-12
2025-02-14
PREVOZNIK MICHAEL
SVP & General Counsel
A - Grant
Common Stock
2,345
$0.00
1
$20.07B
2025-02-12
2025-02-14
SAMAD SAM
Executive Vice President & CFO
A - Grant
Non-Qualifed Stock Option (right to buy)
17,403
$0.00
1
$20.07B
2025-02-12
2025-02-14
SAMAD SAM
Executive Vice President & CFO
A - Grant
Common Stock
4,538
$0.00
1
$20.07B
2025-02-12
2025-02-14
DEPPE MICHAEL
SVP, Corp. Controller & CAO
A - Grant
Non-Qualifed Stock Option (right to buy)
1,738
$0.00
1
$20.07B
2025-02-12
2025-02-14
DAVIS
CEO and President
A - Grant
Non-Qualifed Stock Option (right to buy)
69,633
$0.00
1
$20.07B
2025-02-12
2025-02-14
DAVIS
CEO and President
A - Grant
Common Stock
18,149
$0.00
1
$20.07B
2025-02-12
2025-02-14
DELANEY MARK
SVP & Chief Commercial Officer
A - Grant
Non-Qualifed Stock Option (right to buy)
6,960
$0.00
1
$20.07B
2025-02-12
2025-02-14
DELANEY MARK
SVP & Chief Commercial Officer
A - Grant
Common Stock
1,815
$0.00
1
$20.07B
2025-02-12
2025-02-14
DEPPE MICHAEL
SVP, Corp. Controller & CAO
A - Grant
Common Stock
454
$0.00
1
$20.07B
2025-02-12
2025-02-14
DOHERTY CATHERINE
EVP, Regional Businesses
A - Grant
Non-Qualifed Stock Option (right to buy)
13,344
$0.00
1
$20.07B
2025-02-12
2025-02-14
DOHERTY CATHERINE
EVP, Regional Businesses
A - Grant
Common Stock
3,479
$0.00
1
$20.07B
2025-02-12
2025-02-14
KUPPUSAMY KARTHIK
SVP, Clinical Solutions
A - Grant
Non-Qualifed Stock Option (right to buy)
8,702
$0.00
1
$20.07B
2025-02-12
2025-02-14
KUPPUSAMY KARTHIK
SVP, Clinical Solutions
A - Grant
Common Stock
2,269
$0.00
1
$20.07B
2025-02-05
2025-02-07
DELANEY MARK
SVP & Chief Commercial Officer
S - Sale
Common Stock
-403
$164.00
-66,092
1
$20.07B
2025-02-05
2025-02-07
GREGG VICKY
S - Sale
Common Stock
-1,250
$165.00
-206K
1
$20.07B
2025-01-31
2025-01-31
DELANEY MARK
SVP & Chief Commercial Officer
S - Sale
-2,615
$165.00
-431K
1
$20.07B
2025-01-29
2025-01-31
SAMAD SAM
Executive Vice President & CFO
L - Small Acquisition
Common Stock
35
$158.00
5,530
1
$20.07B
2025-01-29
2025-01-31
DELANEY MARK
SVP & Chief Commercial Officer
L - Small Acquisition
Common Stock
4
$158.00
632
1
$20.07B
2025-01-29
2025-01-31
GREGG VICKY
L - Small Acquisition
Common Stock
72
$158.00
11,376
1
$20.07B
2025-01-29
2025-01-31
KUPPUSAMY KARTHIK
SVP, Clinical Solutions
L - Small Acquisition
Common Stock
12
$158.00
1,896
1
$20.07B
2025-01-29
2025-01-31
PLEWMAN PATRICK
SVP for Diagnostic Services
L - Small Acquisition
Common Stock
57
$158.00
9,006
1
$20.07B
2025-01-02
2025-01-06
RING TIMOTHY
A - Grant
Phantom Stock Units
281
$0.00
1
$20.07B
2025-01-02
2025-01-06
LASSITER WRIGHT III
A - Grant
Phantom Stock Units
190
$0.00
1
$20.07B
2024-11-29
2024-12-02
PREVOZNIK MICHAEL
SVP & General Counsel
M - Exercise
Non-Qualifed Stock Option (right to buy)
-35,146
$87.00
-3.06M
1
$20.07B
2024-11-29
2024-12-02
PREVOZNIK MICHAEL
SVP & General Counsel
M - Exercise
Common Stock
35,146
$87.00
3.06M
1
$20.07B
2024-11-29
2024-12-02
PREVOZNIK MICHAEL
SVP & General Counsel
S - Sale
Common Stock
-35,146
$163.00
-5.73M
2
$20.07B
2024-11-27
2024-12-02
DOHERTY CATHERINE
EVP, Regional Businesses
M - Exercise
Common Stock
33,103
$104.00
3.44M
1
$20.07B
2024-11-27
2024-12-02
DOHERTY CATHERINE
EVP, Regional Businesses
M - Exercise
Non-Qualifed Stock Option (right to buy)
-33,103
$104.00
-3.44M
1
$20.07B
2024-11-27
2024-12-02
DOHERTY CATHERINE
EVP, Regional Businesses
S - Sale
Common Stock
-33,103
$163.00
-5.40M
2
$20.07B
2024-11-06
2024-11-07
DEPPE MICHAEL
SVP, Corp. Controller & CAO
M - Exercise
Non-Qualifed Stock Option (right to buy)
-18,755
$69.00
-1.29M
2
$20.07B
2024-11-06
2024-11-07
DEPPE MICHAEL
SVP, Corp. Controller & CAO
M - Exercise
Common Stock
18,755
$69.00
1.29M
2
$20.07B
2024-11-06
2024-11-07
DEPPE MICHAEL
SVP, Corp. Controller & CAO
S - Sale
Common Stock
-18,755
$154.00
-2.89M
6
$20.07B
2024-10-28
2024-10-30
KUPPUSAMY KARTHIK
SVP, Clinical Solutions
S - Sale
Common Stock
-1,775
$157.00
-279K
1
$20.07B
2024-10-21
2024-10-25
DELANEY MARK
SVP & Chief Commercial Officer
L - Small Acquisition
Common Stock
4
$149.00
596
1
$20.07B
2024-10-21
2024-10-25
GREGG VICKY
L - Small Acquisition
Common Stock
76
$149.00
11,324
1
$20.07B
2024-10-21
2024-10-25
KUPPUSAMY KARTHIK
SVP, Clinical Solutions
L - Small Acquisition
Common Stock
21
$149.00
3,129
1
$20.07B
2024-10-21
2024-10-25
PLEWMAN PATRICK
SVP for Diagnostic Services
L - Small Acquisition
Common Stock
60
$149.00
8,940
1
$20.07B
2024-10-21
2024-10-25
SAMAD SAM
Executive Vice President & CFO
L - Small Acquisition
Common Stock
37
$149.00
5,513
1
$20.07B
2024-10-01
2024-10-03
RING TIMOTHY
A - Grant
Phantom Stock Units
275
$0.00
1
$20.07B
2024-09-24
2024-09-26
GARDNER MARK
SVP of Molecular Gen & Oncol
F - Tax
Common Stock
-120
$156.00
-18,720
1
$20.07B
2024-08-29
2024-09-03
PREVOZNIK MICHAEL
SVP & General Counsel
M - Exercise
Common Stock
32,551
$96.00
3.12M
1
$20.07B
2024-08-29
2024-09-03
PREVOZNIK MICHAEL
SVP & General Counsel
S - Sale
Common Stock
-32,551
$155.00
-5.05M
1
$20.07B
2024-08-29
2024-09-03
PREVOZNIK MICHAEL
SVP & General Counsel
M - Exercise
Non-Qualifed Stock Option (right to buy)
-32,551
$96.00
-3.12M
1
$20.07B
2024-08-28
2024-08-29
KUPPUSAMY KARTHIK
SVP, Clinical Solutions
S - Sale
Common Stock
-1,990
$153.00
-304K
1
$20.07B
2024-08-14
2024-08-16
KUPPUSAMY KARTHIK
SVP, Clinical Solutions
F - Tax
Common Stock
-74
$149.00
-11,026
1
$20.07B
2024-07-24
2024-07-26
DELANEY MARK
SVP & Chief Commercial Officer
S - Sale
Common Stock
-420
$143.00
-60,060
1
$20.07B
2024-07-22
2024-07-26
DELANEY MARK
SVP & Chief Commercial Officer
L - Small Acquisition
Common Stock
6
$147.00
882
1
$20.07B
2024-07-22
2024-07-26
GREGG VICKY
L - Small Acquisition
Common Stock
77
$147.00
11,319
1
$20.07B
2024-07-22
2024-07-26
KUPPUSAMY KARTHIK
SVP, Clinical Solutions
L - Small Acquisition
Common Stock
31
$147.00
4,557
1
$20.07B
2024-07-22
2024-07-26
PLEWMAN PATRICK
SVP for Diagnostic Services
L - Small Acquisition
Common Stock
60
$147.00
8,820
1
$20.07B
2024-07-22
2024-07-26
SAMAD SAM
Executive Vice President & CFO
L - Small Acquisition
Common Stock
21
$147.00
3,087
1
$20.07B
2024-07-16
2024-07-18
SAMAD SAM
Executive Vice President & CFO
F - Tax
Common Stock
-3,910
$143.00
-559K
1
$20.07B
2024-07-01
2024-07-02
RING TIMOTHY
A - Grant
Phantom Stock Units
308
$0.00
1
$20.07B
2024-05-16
2024-05-20
CARTER ROBERT
A - Grant
Common Stock
1,482
$0.00
1
$20.07B
2024-05-16
2024-05-20
LASSITER WRIGHT III
A - Grant
Common Stock
1,482
$0.00
1
$20.07B
2024-05-16
2024-05-20
MAIN TIMOTHY
A - Grant
Common Stock
1,482
$0.00
1
$20.07B
2024-05-16
2024-05-20
MORRISON DENISE
A - Grant
Common Stock
1,482
$0.00
1
$20.07B
2024-05-16
2024-05-20
PFEIFFER GARY
A - Grant
Common Stock
1,482
$0.00
1
$20.07B
2024-05-16
2024-05-20
RING TIMOTHY
A - Grant
Common Stock
1,482
$0.00
1
$20.07B
2024-05-16
2024-05-20
DIAZ LUIS
A - Grant
Common Stock
1,482
$0.00
1
$20.07B
2024-05-16
2024-05-20
DOI TRACEY
A - Grant
Common Stock
1,482
$0.00
1
$20.07B
2024-05-16
2024-05-20
GREGG VICKY
A - Grant
Common Stock
1,482
$0.00
1
$20.07B
2024-04-29
2024-05-01
KUPPUSAMY KARTHIK
SVP, Clinical Solutions
S - Sale
Common Stock
-1,760
$140.00
-246K
1
$20.07B
2024-04-22
2024-04-26
KUPPUSAMY KARTHIK
SVP, Clinical Solutions
A - Grant
Common Stock
45
$126.00
5,670
1
$20.07B
2024-04-22
2024-04-26
PLEWMAN PATRICK
SVP for Diagnostic Services
A - Grant
Common Stock
69
$126.00
8,694
1
$20.07B
2024-04-22
2024-04-26
SAMAD SAM
Executive Vice President & CFO
A - Grant
Common Stock
24
$126.00
3,024
1
$20.07B
2024-04-22
2024-04-26
GREGG VICKY
A - Grant
Common Stock
81
$126.00
10,206
1
$20.07B
2024-04-25
2024-04-25
DELANEY MARK
SVP & Chief Commercial Officer
S - Sale
-406
$135.00
-54,810
1
$20.07B
2024-04-01
2024-04-03
RING TIMOTHY
A - Grant
Phantom Stock Units
311
$0.00
1
$20.07B
2024-03-26
2024-03-28
DELANEY MARK
SVP & Chief Commercial Officer
F - Tax
Common Stock
-170
$128.00
-21,760
1
$20.07B
2024-03-26
2024-03-28
PLEWMAN PATRICK
SVP for Diagnostic Services
F - Tax
Common Stock
-114
$128.00
-14,592
1
$20.07B
2024-02-29
2024-03-01
DOHERTY CATHERINE
EVP, Regional Businesses
S - Sale
Common Stock
-1,187
$126.00
-150K
1
$20.07B
2024-02-29
2024-03-01
PREVOZNIK MICHAEL
SVP & General Counsel
S - Sale
Common Stock
-5,611
$126.00
-707K
1
$20.07B
2024-02-28
2024-03-01
KUPPUSAMY KARTHIK
SVP, Clinical Solutions
F - Tax
Common Stock
-273
$126.00
-34,398
2
$20.07B
2024-02-28
2024-03-01
DOHERTY CATHERINE
EVP, Regional Businesses
S - Sale
Common Stock
-5,557
$127.00
-706K
1
$20.07B
2024-02-28
2024-03-01
DAVIS
CEO and President
F - Tax
Common Stock
-5,020
$126.00
-633K
2
$20.07B
2024-02-28
2024-03-01
DELANEY MARK
SVP & Chief Commercial Officer
F - Tax
Common Stock
-225
$126.00
-28,350
1
$20.07B
2024-02-28
2024-03-01
DEPPE MICHAEL
SVP, Corp. Controller & CAO
F - Tax
Common Stock
-109
$126.00
-13,734
2
$20.07B
2024-02-28
2024-03-01
DOHERTY CATHERINE
EVP, Regional Businesses
F - Tax
Common Stock
-1,201
$126.00
-151K
2
$20.07B
2024-02-28
2024-03-01
GARDNER MARK
SVP of Molecular Gen & Oncol
F - Tax
Common Stock
-262
$126.00
-33,012
1
$20.07B
2024-02-28
2024-03-01
PLEWMAN PATRICK
SVP for Diagnostic Services
F - Tax
Common Stock
-333
$126.00
-41,958
2
$20.07B
2024-02-28
2024-03-01
PREVOZNIK MICHAEL
SVP & General Counsel
F - Tax
Common Stock
-861
$126.00
-108K
2
$20.07B
2024-02-28
2024-03-01
SAMAD SAM
Executive Vice President & CFO
F - Tax
Common Stock
-656
$126.00
-82,656
1
$20.07B
2024-02-23
2024-02-27
DAVIS
CEO and President
A - Grant
Common Stock
13,390
$125.00
1.67M
1
$20.07B
2024-02-23
2024-02-27
DEPPE MICHAEL
SVP, Corp. Controller & CAO
A - Grant
Common Stock
1,689
$125.00
211K
1
$20.07B
2024-02-23
2024-02-27
DOHERTY CATHERINE
EVP, Regional Businesses
A - Grant
Common Stock
9,314
$125.00
1.16M
1
$20.07B
2024-02-23
2024-02-27
KUPPUSAMY KARTHIK
SVP, Clinical Solutions
A - Grant
Common Stock
2,039
$125.00
255K
1
$20.07B
2024-02-23
2024-02-27
PLEWMAN PATRICK
SVP for Diagnostic Services
A - Grant
Common Stock
2,388
$125.00
299K
1
$20.07B
2024-02-23
2024-02-27
PREVOZNIK MICHAEL
SVP & General Counsel
A - Grant
Common Stock
7,569
$125.00
946K
1
$20.07B
2024-02-23
2024-02-27
DAVIS
CEO and President
F - Tax
Common Stock
-6,525
$125.00
-816K
1
$20.07B
2024-02-23
2024-02-27
DEPPE MICHAEL
SVP, Corp. Controller & CAO
F - Tax
Common Stock
-631
$125.00
-78,875
1
$20.07B
2024-02-23
2024-02-27
DOHERTY CATHERINE
EVP, Regional Businesses
F - Tax
Common Stock
-3,757
$125.00
-470K
1
$20.07B
2024-02-23
2024-02-27
KUPPUSAMY KARTHIK
SVP, Clinical Solutions
F - Tax
Common Stock
-619
$125.00
-77,375
1
$20.07B
2024-02-23
2024-02-27
PLEWMAN PATRICK
SVP for Diagnostic Services
F - Tax
Common Stock
-869
$125.00
-109K
1
$20.07B
2024-02-23
2024-02-27
PREVOZNIK MICHAEL
SVP & General Counsel
F - Tax
Common Stock
-2,825
$125.00
-353K
1
$20.07B
2024-02-23
2024-02-23
GREGG VICKY
S - Sale
Common Stock
-2,500
$127.00
-318K
1
$20.07B
2024-02-22
2024-02-23
PREVOZNIK MICHAEL
SVP & General Counsel
S - Sale
Common Stock
-661
$126.00
-83,286
1
$20.07B
2024-02-22
2024-02-23
DOHERTY CATHERINE
EVP, Regional Businesses
S - Sale
Common Stock
-821
$126.00
-103K
1
$20.07B
2024-02-21
2024-02-23
DEPPE MICHAEL
SVP, Corp. Controller & CAO
F - Tax
Common Stock
-89
$125.00
-11,125
1
$20.07B
2024-02-21
2024-02-23
DOHERTY CATHERINE
EVP, Regional Businesses
F - Tax
Common Stock
-493
$125.00
-61,625
1
$20.07B
2024-02-21
2024-02-23
KUPPUSAMY KARTHIK
SVP, Clinical Solutions
F - Tax
Common Stock
-102
$125.00
-12,750
1
$20.07B
2024-02-21
2024-02-23
PLEWMAN PATRICK
SVP for Diagnostic Services
F - Tax
Common Stock
-139
$125.00
-17,375
1
$20.07B
2024-02-21
2024-02-23
PREVOZNIK MICHAEL
SVP & General Counsel
F - Tax
Common Stock
-407
$125.00
-50,875
1
$20.07B
2024-02-21
2024-02-23
DAVIS
CEO and President
F - Tax
Common Stock
-762
$125.00
-95,250
1
$20.07B
2024-02-14
2024-02-16
DELANEY MARK
SVP & Chief Commercial Officer
A - Grant
Common Stock
2,348
$0.00
1
$20.07B
2024-02-14
2024-02-16
DEPPE MICHAEL
SVP, Corp. Controller & CAO
A - Grant
Non-Qualifed Stock Option (right to buy)
2,322
$0.00
1
$20.07B
2024-02-14
2024-02-16
DAVIS
CEO and President
A - Grant
Non-Qualifed Stock Option (right to buy)
92,779
$0.00
1
$20.07B
2024-02-14
2024-02-16
DAVIS
CEO and President
A - Grant
Common Stock
22,251
$0.00
1
$20.07B
2024-02-14
2024-02-16
DELANEY MARK
SVP & Chief Commercial Officer
A - Grant
Non-Qualifed Stock Option (right to buy)
9,783
$0.00
1
$20.07B
2024-02-14
2024-02-16
DEPPE MICHAEL
SVP, Corp. Controller & CAO
A - Grant
Common Stock
558
$0.00
1
$20.07B
2024-02-14
2024-02-16
DOHERTY CATHERINE
SVP, Regional Businesses
A - Grant
Non-Qualifed Stock Option (right to buy)
17,939
$0.00
1
$20.07B
2024-02-14
2024-02-16
DOHERTY CATHERINE
SVP, Regional Businesses
A - Grant
Common Stock
4,304
$0.00
1
$20.07B
2024-02-14
2024-02-16
GARDNER MARK
SVP of Molecular Gen & Oncol
A - Grant
Non-Qualifed Stock Option (right to buy)
9,376
$0.00
1
$20.07B
2024-02-14
2024-02-16
GARDNER MARK
SVP of Molecular Gen & Oncol
A - Grant
Common Stock
2,250
$0.00
1
$20.07B
2024-02-14
2024-02-16
KUPPUSAMY KARTHIK
SVP, Clinical Solutions
A - Grant
Non-Qualifed Stock Option (right to buy)
11,007
$0.00
1
$20.07B
2024-02-14
2024-02-16
KUPPUSAMY KARTHIK
SVP, Clinical Solutions
A - Grant
Common Stock
2,641
$0.00
1
$20.07B
2024-02-14
2024-02-16
PLEWMAN PATRICK
SVP for Diagnostic Services
A - Grant
Non-Qualifed Stock Option (right to buy)
10,190
$0.00
1
$20.07B
2024-02-14
2024-02-16
PLEWMAN PATRICK
SVP for Diagnostic Services
A - Grant
Common Stock
2,446
$0.00
1
$20.07B
2024-02-14
2024-02-16
PREVOZNIK MICHAEL
SVP & General Counsel
A - Grant
Non-Qualifed Stock Option (right to buy)
12,231
$0.00
1
$20.07B
2024-02-14
2024-02-16
PREVOZNIK MICHAEL
SVP & General Counsel
A - Grant
Common Stock
2,935
$0.00
1
$20.07B
2024-02-14
2024-02-16
SAMAD SAM
Executive Vice President & CFO
A - Grant
Non-Qualifed Stock Option (right to buy)
22,835
$0.00
1
$20.07B
2024-02-14
2024-02-16
SAMAD SAM
Executive Vice President & CFO
A - Grant
Common Stock
5,478
$0.00
1
$20.07B
2024-01-31
2024-02-02
SAMAD SAM
Executive Vice President & CFO
A - Grant
Common Stock
17
$129.00
2,193
1
$20.07B
2024-01-31
2024-02-02
GREGG VICKY
A - Grant
Common Stock
88
$129.00
11,352
1
$20.07B
2024-01-31
2024-02-02
KUPPUSAMY KARTHIK
SVP, Clinical Solutions
A - Grant
Common Stock
29
$129.00
3,741
1
$20.07B
2024-01-31
2024-02-02
PLEWMAN PATRICK
SVP for Diagnostic Services
A - Grant
Common Stock
50
$129.00
6,450
1
$20.07B
2023-05-10
2024-01-19
PREVOZNIK MICHAEL
SVP & General Counsel
G - Gift
Common Stock
-188
$0.00
1
$20.07B
2024-01-02
2024-01-04
RING TIMOTHY
A - Grant
Phantom Stock Units
294
$0.00
1
$20.07B
2023-10-23
2023-10-26
GREGG VICKY
A - Grant
Common Stock
92
$123.00
11,316
1
$20.07B
2023-10-23
2023-10-26
KUPPUSAMY KARTHIK
SVP, Clinical Solutions
A - Grant
Common Stock
30
$123.00
3,690
1
$20.07B
2023-10-23
2023-10-26
PLEWMAN PATRICK
SVP for Diagnostic Services
A - Grant
Common Stock
52
$123.00
6,396
1
$20.07B
2023-10-23
2023-10-26
SAMAD SAM
Executive Vice President & CFO
A - Grant
Common Stock
18
$123.00
2,214
1
$20.07B
2023-10-02
2023-10-04
RING TIMOTHY
A - Grant
Phantom Stock Units
344
$0.00
1
$20.07B
2023-09-25
2023-09-27
GARDNER MARK
SVP of Molecular Gen & Oncol
F - Tax
Common Stock
-116
$126.00
-14,616
1
$20.07B
2023-08-15
2023-08-17
KUPPUSAMY KARTHIK
SVP, Clinical Solutions
F - Tax
Common Stock
-74
$135.00
-9,990
1
$20.07B
2023-07-25
2023-07-27
GREGG VICKY
A - Grant
Common Stock
78
$145.00
11,310
1
$20.07B
2023-07-25
2023-07-27
KUPPUSAMY KARTHIK
SVP, Clinical Solutions
A - Grant
Common Stock
25
$145.00
3,625
1
$20.07B
2023-07-25
2023-07-27
PLEWMAN PATRICK
SVP for Diagnostic Services
A - Grant
Common Stock
44
$145.00
6,380
1
$20.07B
2023-07-14
2023-07-17
SAMAD SAM
Executive Vice President & CFO
F - Tax
Common Stock
-3,909
$140.00
-547K
1
$20.07B
2023-07-03
2023-07-05
RING TIMOTHY
A - Grant
Phantom Stock Units
297
$0.00
1
$20.07B
2023-05-17
2023-05-19
GREGG VICKY
A - Grant
Common Stock
1,369
$0.00
1
$20.07B
2023-05-17
2023-05-19
LASSITER WRIGHT III
A - Grant
Common Stock
1,369
$0.00
1
$20.07B
2023-05-17
2023-05-19
MAIN TIMOTHY
A - Grant
Common Stock
1,369
$0.00
1
$20.07B
2023-05-17
2023-05-19
MORRISON DENISE
A - Grant
Common Stock
1,369
$0.00
1
$20.07B
2023-05-17
2023-05-19
PFEIFFER GARY
A - Grant
Common Stock
1,369
$0.00
1
$20.07B
2023-05-17
2023-05-19
RING TIMOTHY
A - Grant
Common Stock
1,369
$0.00
1
$20.07B
2023-05-17
2023-05-19
WILENSKY GAIL
A - Grant
Common Stock
1,369
$0.00
1
$20.07B
2023-05-17
2023-05-19
DIAZ LUIS
A - Grant
Common Stock
1,369
$0.00
1
$20.07B
2023-05-17
2023-05-19
DOI TRACEY
A - Grant
Common Stock
1,369
$0.00
1
$20.07B
2023-04-24
2023-04-25
GREGG VICKY
L - Small Acquisition
Common Stock
72
$143.00
10,296
1
$20.07B
2023-04-24
2023-04-25
KUPPUSAMY KARTHIK
SVP, Clinical Solutions
L - Small Acquisition
Common Stock
25
$143.00
3,575
1
$20.07B
2023-04-24
2023-04-25
PLEWMAN PATRICK
SVP for Diagnostic Services
L - Small Acquisition
Common Stock
44
$143.00
6,292
1
$20.07B
2023-04-03
2023-04-04
RING TIMOTHY
A - Grant
Phantom Stock Units
291
$0.00
1
$20.07B
2023-03-24
2023-03-27
DELANEY MARK
SVP & Chief Commercial Officer
F - Tax
Common Stock
-170
$134.00
-22,780
1
$20.07B
2023-03-24
2023-03-27
PLEWMAN PATRICK
SVP for Diagnostic Services
F - Tax
Common Stock
-99
$134.00
-13,266
1
$20.07B
2023-03-07
2023-03-08
DOHERTY CATHERINE
SVP, Regional Businesses
S - Sale
Common Stock
-5,307
$141.00
-748K
1
$20.07B
2023-03-07
2023-03-08
PREVOZNIK MICHAEL
SVP & General Counsel
S - Sale
Common Stock
-4,754
$141.00
-670K
1
$20.07B
2023-03-06
2023-03-08
DAVIS
CEO and President
A - Grant
Common Stock
15,204
$148.00
2.25M
1
$20.07B
2023-03-06
2023-03-08
DEPPE MICHAEL
SVP, Corp. Controller & CAO
A - Grant
Common Stock
1,918
$148.00
284K
1
$20.07B
2023-03-06
2023-03-08
DOHERTY CATHERINE
SVP, Regional Businesses
A - Grant
Common Stock
9,917
$148.00
1.47M
1
$20.07B
2023-03-06
2023-03-08
KUPPUSAMY KARTHIK
SVP, Clinical Solutions
A - Grant
Common Stock
1,985
$148.00
294K
1
$20.07B
2023-03-06
2023-03-08
PLEWMAN PATRICK
SVP for Diagnostic Services
A - Grant
Common Stock
2,579
$148.00
382K
1
$20.07B
2023-03-06
2023-03-08
PREVOZNIK MICHAEL
SVP & General Counsel
A - Grant
Common Stock
8,595
$148.00
1.27M
1
$20.07B
2023-03-06
2023-03-08
RUSCKOWSKI STEPHEN
A - Grant
Common Stock
82,631
$148.00
12M
1
$20.07B
2023-03-06
2023-03-08
DAVIS
CEO and President
F - Tax
Common Stock
-8,036
$148.00
-1.19M
1
$20.07B
2023-03-06
2023-03-08
DEPPE MICHAEL
SVP, Corp. Controller & CAO
F - Tax
Common Stock
-682
$148.00
-101K
1
$20.07B
2023-03-06
2023-03-08
DOHERTY CATHERINE
SVP, Regional Businesses
F - Tax
Common Stock
-4,610
$148.00
-682K
1
$20.07B
2023-03-06
2023-03-08
KUPPUSAMY KARTHIK
SVP, Clinical Solutions
F - Tax
Common Stock
-583
$148.00
-86,284
1
$20.07B
2023-03-06
2023-03-08
PLEWMAN PATRICK
SVP for Diagnostic Services
F - Tax
Common Stock
-799
$148.00
-118K
1
$20.07B
2023-03-06
2023-03-08
PREVOZNIK MICHAEL
SVP & General Counsel
F - Tax
Common Stock
-3,841
$148.00
-568K
1
$20.07B
2023-03-06
2023-03-08
RUSCKOWSKI STEPHEN
F - Tax
Common Stock
-38,604
$148.00
-5.71M
1
$20.07B
2023-03-03
2023-03-06
DOHERTY CATHERINE
SVP, Regional Businesses
S - Sale
Common Stock
-717
$141.00
-101K
1
$20.07B
2023-03-02
2023-03-03
PREVOZNIK MICHAEL
SVP & General Counsel
S - Sale
Common Stock
-593
$139.00
-82,427
1
$20.07B
2023-03-01
2023-03-03
DAVIS
CEO and President
F - Tax
Common Stock
-1,292
$141.00
-182K
1
$20.07B
2023-03-01
2023-03-03
DEPPE MICHAEL
SVP, Corp. Controller & CAO
F - Tax
Common Stock
-68
$141.00
-9,588
1
$20.07B
2023-03-01
2023-03-03
DOHERTY CATHERINE
SVP, Regional Businesses
F - Tax
Common Stock
-392
$141.00
-55,272
1
$20.07B
2023-03-01
2023-03-03
KUPPUSAMY KARTHIK
SVP, Clinical Solutions
F - Tax
Common Stock
-65
$141.00
-9,165
1
$20.07B
2023-03-01
2023-03-03
PLEWMAN PATRICK
SVP for Diagnostic Services
F - Tax
Common Stock
-90
$141.00
-12,690
1
$20.07B
2023-03-01
2023-03-03
PREVOZNIK MICHAEL
SVP & General Counsel
F - Tax
Common Stock
-320
$141.00
-45,120
1
$20.07B
2023-03-01
2023-03-03
RUSCKOWSKI STEPHEN
F - Tax
Common Stock
-3,496
$141.00
-493K
1
$20.07B
2023-02-27
2023-02-27
DOHERTY CATHERINE
SVP, Regional Businesses
A - Grant
Non-Qualifed Stock Option (right to buy)
15,167
$0.00
1
$20.07B
2023-02-24
2023-02-27
PREVOZNIK MICHAEL
SVP & General Counsel
S - Sale
Common Stock
-1,415
$141.00
-200K
1
$20.07B
2023-02-24
2023-02-27
DOHERTY CATHERINE
SVP, Regional Businesses
S - Sale
Common Stock
-1,690
$141.00
-238K
1
$20.07B
2023-02-23
2023-02-27
KUPPUSAMY KARTHIK
SVP, Clinical Solutions
A - Grant
Common Stock
2,094
$0.00
1
$20.07B
2023-02-23
2023-02-27
DAVIS
CEO and President
A - Grant
Non-Qualifed Stock Option (right to buy)
68,956
$0.00
1
$20.07B
2023-02-23
2023-02-27
DAVIS
CEO and President
A - Grant
Common Stock
17,443
$0.00
1
$20.07B
2023-02-23
2023-02-27
DELANEY MARK
SVP & Chief Commercial Officer
A - Grant
Non-Qualifed Stock Option (right to buy)
7,584
$0.00
1
$20.07B
2023-02-23
2023-02-27
DELANEY MARK
SVP & Chief Commercial Officer
A - Grant
Common Stock
1,919
$0.00
1
$20.07B
2023-02-23
2023-02-27
DEPPE MICHAEL
SVP, Corp. Controller & CAO
A - Grant
Non-Qualifed Stock Option (right to buy)
1,960
$0.00
1
$20.07B
2023-02-23
2023-02-27
DEPPE MICHAEL
SVP, Corp. Controller & CAO
A - Grant
Common Stock
498
$0.00
1
$20.07B
2023-02-23
2023-02-27
DOHERTY CATHERINE
SVP, Regional Businesses
A - Grant
Common Stock
3,838
$0.00
1
$20.07B
2023-02-23
2023-02-27
PLEWMAN PATRICK
SVP for Diagnostic Services
A - Grant
Non-Qualifed Stock Option (right to buy)
7,584
$0.00
1
$20.07B
2023-02-23
2023-02-27
GARDNER MARK
SVP of Molecular Gen & Oncol
A - Grant
Non-Qualifed Stock Option (right to buy)
7,584
$0.00
1
$20.07B
2023-02-23
2023-02-27
PREVOZNIK MICHAEL
SVP & General Counsel
A - Grant
Non-Qualifed Stock Option (right to buy)
9,653
$0.00
1
$20.07B
2023-02-23
2023-02-27
PREVOZNIK MICHAEL
SVP & General Counsel
A - Grant
Common Stock
2,442
$0.00
1
$20.07B
2023-02-23
2023-02-27
RUSCKOWSKI STEPHEN
A - Grant
Common Stock
20,059
$0.00
1
$20.07B
2023-02-23
2023-02-27
SAMAD SAM
Executive Vice President & CFO
A - Grant
Non-Qualifed Stock Option (right to buy)
18,616
$0.00
1
$20.07B
2023-02-23
2023-02-27
SAMAD SAM
Executive Vice President & CFO
A - Grant
Common Stock
4,710
$0.00
1
$20.07B
2023-02-23
2023-02-27
DAVIS
CEO and President
F - Tax
Common Stock
-1,473
$148.00
-218K
1
$20.07B
2023-02-23
2023-02-27
DEPPE MICHAEL
SVP, Corp. Controller & CAO
F - Tax
Common Stock
-188
$148.00
-27,824
1
$20.07B
2023-02-23
2023-02-27
DOHERTY CATHERINE
SVP, Regional Businesses
F - Tax
Common Stock
-962
$148.00
-142K
1
$20.07B
2023-02-23
2023-02-27
KUPPUSAMY KARTHIK
SVP, Clinical Solutions
F - Tax
Common Stock
-195
$148.00
-28,860
1
$20.07B
2023-02-23
2023-02-27
PLEWMAN PATRICK
SVP for Diagnostic Services
F - Tax
Common Stock
-245
$148.00
-36,260
1
$20.07B
2023-02-23
2023-02-27
PREVOZNIK MICHAEL
SVP & General Counsel
F - Tax
Common Stock
-811
$148.00
-120K
1
$20.07B
2023-02-23
2023-02-27
RUSCKOWSKI STEPHEN
F - Tax
Common Stock
-5,826
$148.00
-862K
1
$20.07B
2023-02-23
2023-02-27
PLEWMAN PATRICK
SVP for Diagnostic Services
A - Grant
Common Stock
1,919
$0.00
1
$20.07B
2023-02-23
2023-02-27
GARDNER MARK
SVP of Molecular Gen & Oncol
A - Grant
Common Stock
1,919
$0.00
1
$20.07B
2023-02-23
2023-02-27
KUPPUSAMY KARTHIK
SVP, Clinical Solutions
A - Grant
Non-Qualifed Stock Option (right to buy)
8,270
$0.00
1
$20.07B
2023-02-01
2023-02-03
KUPPUSAMY KARTHIK
SVP, Clinical Solutions
L - Small Acquisition
Common Stock
13
$147.00
1,911
1
$20.07B
2023-02-01
2023-02-03
GREGG VICKY
L - Small Acquisition
Common Stock
64
$147.00
9,408
1
$20.07B
2023-02-01
2023-02-03
PLEWMAN PATRICK
SVP for Diagnostic Services
L - Small Acquisition
Common Stock
27
$147.00
3,969
1
$20.07B
2023-01-03
2023-01-04
RING TIMOTHY
A - Grant
Phantom Stock Units
267
$0.00
1
$20.07B
2022-12-01
2022-12-05
RING TIMOTHY
M - Exercise
Stock Options (Right to Buy)
-2,025
$57.00
-115K
2
$20.07B
2022-12-01
2022-12-05
RING TIMOTHY
M - Exercise
Common Stock
2,025
$57.00
115K
2
$20.07B
2022-12-01
2022-12-05
RING TIMOTHY
S - Sale
Common Stock
-2,025
$153.00
-310K
1
$20.07B
2022-11-28
2022-11-29
DOHERTY CATHERINE
SVP, Regional Businesses
M - Exercise
Non-Qualifed Stock Option (right to buy)
-40,765
$87.00
-3.55M
1
$20.07B
2022-11-28
2022-11-29
DOHERTY CATHERINE
SVP, Regional Businesses
M - Exercise
Common Stock
40,765
$87.00
3.55M
1
$20.07B
2022-11-28
2022-11-29
DOHERTY CATHERINE
SVP, Regional Businesses
S - Sale
Common Stock
-40,765
$149.00
-6.07M
2
$20.07B
2022-11-01
2022-11-03
DAVIS
CEO and President
A - Grant
Common Stock
13,980
$0.00
1
$20.07B
2022-11-01
2022-11-02
RING TIMOTHY
M - Exercise
Stock Options (Right to Buy)
-2,000
$61.00
-122K
3
$20.07B
2022-11-01
2022-11-02
RING TIMOTHY
M - Exercise
Common Stock
2,000
$61.00
122K
3
$20.07B
2022-11-01
2022-11-02
RING TIMOTHY
S - Sale
Common Stock
-2,000
$144.00
-288K
1
$20.07B
2022-10-26
2022-10-27
DEPPE MICHAEL
VP, Corp. Controller & CAO
S - Sale
Common Stock
-15,497
$145.00
-2.25M
1
$20.07B
2022-10-26
2022-10-27
DEPPE MICHAEL
VP, Corp. Controller & CAO
M - Exercise
Non-Qualifed Stock Option (right to buy)
-15,497
$54.00
-837K
2
$20.07B
2022-10-26
2022-10-27
DEPPE MICHAEL
VP, Corp. Controller & CAO
M - Exercise
Common Stock
15,497
$54.00
837K
2
$20.07B
2022-10-19
2022-10-21
GREGG VICKY
L - Small Acquisition
Common Stock
74
$128.00
9,472
1
$20.07B
2022-10-03
2022-10-04
RING TIMOTHY
A - Grant
Phantom Stock Units
333
$0.00
1
$20.07B
2022-10-03
2022-10-04
RING TIMOTHY
M - Exercise
Stock Options (Right to Buy)
-2,000
$61.00
-122K
1
$20.07B
2022-10-03
2022-10-04
RING TIMOTHY
S - Sale
Common Stock
-2,000
$123.00
-246K
1
$20.07B
2022-10-03
2022-10-04
RING TIMOTHY
M - Exercise
Common Stock
2,000
$61.00
122K
1
$20.07B
2022-09-01
2022-09-06
RING TIMOTHY
M - Exercise
Stock Options (Right to Buy)
-2,000
$61.00
-122K
1
$20.07B
2022-09-01
2022-09-06
RING TIMOTHY
M - Exercise
Common Stock
2,000
$61.00
122K
1
$20.07B
2022-09-01
2022-09-06
RING TIMOTHY
S - Sale
Common Stock
-2,000
$125.00
-250K
1
$20.07B
2022-08-01
2022-08-02
RING TIMOTHY
M - Exercise
Stock Options (Right to Buy)
-2,000
$61.00
-122K
2
$20.07B
2022-08-01
2022-08-02
RING TIMOTHY
M - Exercise
Common Stock
2,000
$61.00
122K
2
$20.07B
2022-08-01
2022-08-02
RING TIMOTHY
S - Sale
Common Stock
-2,000
$136.00
-272K
1
$20.07B
2022-07-20
2022-07-21
GREGG VICKY
L - Small Acquisition
Common Stock
70
$134.00
9,380
1
$20.07B
2022-07-01
2022-07-05
RING TIMOTHY
A - Grant
Phantom Stock Units
308
$135.00
41,580
1
$20.07B
2022-07-01
2022-07-05
RING TIMOTHY
M - Exercise
Stock Options (Right to Buy)
-2,000
$57.00
-114K
2
$20.07B
2022-07-01
2022-07-05
RING TIMOTHY
S - Sale
Common Stock
-2,000
$133.00
-266K
1
$20.07B
2022-07-01
2022-07-05
RING TIMOTHY
M - Exercise
Common Stock
2,000
$57.00
114K
2
$20.07B
2022-05-25
2022-05-26
RUSCKOWSKI STEPHEN
Chairman, CEO and President
M - Exercise
Non-Qualifed Stock Option (right to buy)
-24,891
$93.00
-2.31M
2
$20.07B
2022-05-25
2022-05-26
RUSCKOWSKI STEPHEN
Chairman, CEO and President
M - Exercise
Common Stock
24,891
$93.00
2.31M
2
$20.07B
2022-05-25
2022-05-26
RUSCKOWSKI STEPHEN
Chairman, CEO and President
S - Sale
Common Stock
-24,891
$141.00
-3.51M
6
$20.07B
2022-05-24
2022-05-25
RUSCKOWSKI STEPHEN
Chairman, CEO and President
M - Exercise
Non-Qualifed Stock Option (right to buy)
-282K
$94.00
-27M
2
$20.07B
2022-05-24
2022-05-25
RUSCKOWSKI STEPHEN
Chairman, CEO and President
M - Exercise
Common Stock
282K
$94.00
27M
2
$20.07B
2022-05-24
2022-05-25
RUSCKOWSKI STEPHEN
Chairman, CEO and President
S - Sale
Common Stock
-282K
$140.00
-40M
2
$20.07B
2022-05-23
2022-05-25
RUSCKOWSKI STEPHEN
Chairman, CEO and President
M - Exercise
Non-Qualifed Stock Option (right to buy)
-77,466
$94.00
-7.28M
2
$20.07B
2022-05-23
2022-05-25
RUSCKOWSKI STEPHEN
Chairman, CEO and President
S - Sale
Common Stock
-77,466
$140.00
-11M
6
$20.07B
2022-05-23
2022-05-25
RUSCKOWSKI STEPHEN
Chairman, CEO and President
M - Exercise
Common Stock
77,466
$94.00
7.28M
2
$20.07B
2022-05-18
2022-05-20
RING TIMOTHY
A - Grant
Common Stock
1,292
$0.00
1
$20.07B
2022-05-18
2022-05-20
PFEIFFER GARY
A - Grant
Common Stock
1,292
$0.00
1
$20.07B
2022-05-18
2022-05-20
WILENSKY GAIL
A - Grant
Common Stock
1,292
$0.00
1
$20.07B
2022-05-18
2022-05-20
DEPPE MICHAEL
VP, Corp. Controller & CAO
F - Tax
Common Stock
-8
$137.00
-1,096
1
$20.07B
2022-05-18
2022-05-20
DOI TRACEY
A - Grant
Common Stock
1,292
$0.00
1
$20.07B
2022-05-18
2022-05-20
GREGG VICKY
A - Grant
Common Stock
1,292
$0.00
1
$20.07B
2022-05-18
2022-05-20
LASSITER WRIGHT III
A - Grant
Common Stock
1,292
$0.00
1
$20.07B
2022-05-18
2022-05-20
MAIN TIMOTHY
A - Grant
Common Stock
1,292
$0.00
1
$20.07B
2022-05-18
2022-05-20
MORRISON DENISE
A - Grant
Common Stock
1,292
$0.00
1
$20.07B
2022-04-18
2022-05-20
GREGG VICKY
L - Small Acquisition
Common Stock
61
$135.00
8,235
1
$20.07B
2022-05-17
2022-05-19
PREVOZNIK MICHAEL
SVP & General Counsel
M - Exercise
Non-Qualifed Stock Option (right to buy)
-50,604
$67.00
-3.39M
1
$20.07B
2022-05-17
2022-05-19
PREVOZNIK MICHAEL
SVP & General Counsel
M - Exercise
Common Stock
50,604
$67.00
3.39M
1
$20.07B
2022-05-17
2022-05-19
PREVOZNIK MICHAEL
SVP & General Counsel
S - Sale
Common Stock
-50,604
$140.00
-7.08M
1
$20.07B
2022-04-01
2022-04-04
RING TIMOTHY
A - Grant
Phantom Stock Units
306
$135.00
41,310
1
$20.07B
2022-03-08
2022-03-09
PREVOZNIK MICHAEL
SVP & General Counsel
S - Sale
Common Stock
-6,228
$135.00
-841K
1
$20.07B
2022-03-08
2022-03-09
DOHERTY CATHERINE
SVP, Group Exec. Clin. Fran.
S - Sale
Common Stock
-7,032
$135.00
-949K
1
$20.07B
2022-03-07
2022-03-09
DAVIS
EVP-Gen. Diagnostics/CEO Elect
A - Grant
Common Stock
19,856
$130.00
2.58M
1
$20.07B
2022-03-07
2022-03-09
DEPPE MICHAEL
VP, Corp. Controller & CAO
A - Grant
Common Stock
2,516
$130.00
327K
2
$20.07B
2022-03-07
2022-03-09
DOHERTY CATHERINE
SVP, Group Exec. Clin. Fran.
A - Grant
Common Stock
13,392
$130.00
1.74M
1
$20.07B
2022-03-07
2022-03-09
EGLINTON MANNER CARRIE
SVP, Advanced Diagnostics
A - Grant
Common Stock
16,162
$130.00
2.10M
1
$20.07B
2022-03-07
2022-03-09
GUINAN MARK
Executive Vice President & CFO
A - Grant
Common Stock
20,780
$130.00
2.70M
1
$20.07B
2022-03-07
2022-03-09
PREVOZNIK MICHAEL
SVP & General Counsel
A - Grant
Common Stock
11,544
$130.00
1.50M
1
$20.07B
2022-03-07
2022-03-09
RUSCKOWSKI STEPHEN
Chairman, CEO and President
A - Grant
Common Stock
70,184
$130.00
9.12M
1
$20.07B
2022-03-07
2022-03-09
DAVIS
EVP-Gen. Diagnostics/CEO Elect
F - Tax
Common Stock
-10,330
$130.00
-1.34M
1
$20.07B
2022-03-07
2022-03-09
DEPPE MICHAEL
VP, Corp. Controller & CAO
F - Tax
Common Stock
-914
$130.00
-119K
2
$20.07B
2022-03-07
2022-03-09
DOHERTY CATHERINE
SVP, Group Exec. Clin. Fran.
F - Tax
Common Stock
-6,360
$130.00
-827K
1
$20.07B
2022-03-07
2022-03-09
EGLINTON MANNER CARRIE
SVP, Advanced Diagnostics
F - Tax
Common Stock
-7,947
$130.00
-1.03M
1
$20.07B
2022-03-07
2022-03-09
GUINAN MARK
Executive Vice President & CFO
F - Tax
Common Stock
-10,475
$130.00
-1.36M
1
$20.07B
2022-03-07
2022-03-09
PREVOZNIK MICHAEL
SVP & General Counsel
F - Tax
Common Stock
-5,316
$130.00
-691K
1
$20.07B
2022-03-07
2022-03-09
RUSCKOWSKI STEPHEN
Chairman, CEO and President
F - Tax
Common Stock
-32,570
$130.00
-4.23M
1
$20.07B
2022-02-28
2022-03-02
PREVOZNIK MICHAEL
SVP & General Counsel
S - Sale
Common Stock
-661
$130.00
-85,930
1
$20.07B
2022-02-24
2022-02-28
PREVOZNIK MICHAEL
SVP & General Counsel
A - Grant
Common Stock
2,741
$0.00
1
$20.07B
2022-02-24
2022-02-28
DOHERTY CATHERINE
SVP, Group Exec. Clin. Fran.
A - Grant
Common Stock
3,328
$0.00
1
$20.07B
2022-02-24
2022-02-28
EGLINTON MANNER CARRIE
SVP, Advanced Diagnostics
A - Grant
Non-Qualifed Stock Option (right to buy)
19,009
$0.00
1
$20.07B
2022-02-24
2022-02-28
EGLINTON MANNER CARRIE
SVP, Advanced Diagnostics
A - Grant
Common Stock
11,745
$0.00
2
$20.07B
2022-02-24
2022-02-28
GUINAN MARK
Executive Vice President & CFO
A - Grant
Non-Qualifed Stock Option (right to buy)
10,932
$0.00
1
$20.07B
2022-02-24
2022-02-28
GUINAN MARK
Executive Vice President & CFO
A - Grant
Common Stock
2,251
$0.00
1
$20.07B
2022-02-24
2022-02-28
PREVOZNIK MICHAEL
SVP & General Counsel
A - Grant
Non-Qualifed Stock Option (right to buy)
13,301
$0.00
1
$20.07B
2022-02-24
2022-02-28
RUSCKOWSKI STEPHEN
Chairman, CEO and President
A - Grant
Non-Qualifed Stock Option (right to buy)
109K
$0.00
1
$20.07B
2022-02-24
2022-02-28
DOHERTY CATHERINE
SVP, Group Exec. Clin. Fran.
S - Sale
Common Stock
-2,750
$126.00
-347K
1
$20.07B
2022-02-24
2022-02-28
PREVOZNIK MICHAEL
SVP & General Counsel
S - Sale
Common Stock
-1,669
$126.00
-210K
1
$20.07B
2022-02-24
2022-02-28
DAVIS
EVP-Gen. Diagnostics/CEO Elect
A - Grant
Non-Qualifed Stock Option (right to buy)
47,529
$0.00
1
$20.07B
2022-02-24
2022-02-28
DAVIS
EVP-Gen. Diagnostics/CEO Elect
A - Grant
Common Stock
9,787
$0.00
1
$20.07B
2022-02-24
2022-02-28
DEPPE MICHAEL
VP, Corp. Controller & CAO
A - Grant
Non-Qualifed Stock Option (right to buy)
2,654
$0.00
1
$20.07B
2022-02-24
2022-02-28
DEPPE MICHAEL
VP, Corp. Controller & CAO
A - Grant
Common Stock
3,681
$0.00
2
$20.07B
2022-02-24
2022-02-28
DOHERTY CATHERINE
SVP, Group Exec. Clin. Fran.
A - Grant
Non-Qualifed Stock Option (right to buy)
16,155
$0.00
1
$20.07B
2022-02-24
2022-02-28
RUSCKOWSKI STEPHEN
Chairman, CEO and President
A - Grant
Common Stock
22,510
$0.00
1
$20.07B
2022-02-23
2022-02-25
DAVIS
EVP-Gen. Diagnostics/CEO Elect
F - Tax
Common Stock
-2,436
$130.00
-317K
2
$20.07B
2022-02-23
2022-02-25
DEPPE MICHAEL
VP, Corp. Controller & CAO
F - Tax
Common Stock
-313
$130.00
-40,690
2
$20.07B
2022-02-23
2022-02-25
DOHERTY CATHERINE
SVP, Group Exec. Clin. Fran.
F - Tax
Common Stock
-1,574
$130.00
-205K
2
$20.07B
2022-02-23
2022-02-25
EGLINTON MANNER CARRIE
SVP, Advanced Diagnostics
F - Tax
Common Stock
-1,977
$130.00
-257K
2
$20.07B
2022-02-23
2022-02-25
GUINAN MARK
Executive Vice President & CFO
F - Tax
Common Stock
-2,367
$130.00
-308K
2
$20.07B
2022-02-23
2022-02-25
PREVOZNIK MICHAEL
SVP & General Counsel
F - Tax
Common Stock
-1,339
$130.00
-174K
2
$20.07B
2022-02-23
2022-02-25
RUSCKOWSKI STEPHEN
Chairman, CEO and President
F - Tax
Common Stock
-9,718
$130.00
-1.26M
2
$20.07B
2022-01-03
2022-01-04
RING TIMOTHY
A - Grant
Phantom Stock Units
247
$168.00
41,496
1
$20.07B
2021-11-29
2021-12-01
DOHERTY CATHERINE
SVP, Group Exec. Clin. Fran.
M - Exercise
Non-Qualifed Stock Option (right to buy)
-37,565
$96.00
-3.61M
1
$20.07B
2021-11-29
2021-12-01
DOHERTY CATHERINE
SVP, Group Exec. Clin. Fran.
M - Exercise
Common Stock
37,565
$96.00
3.61M
1
$20.07B
2021-11-29
2021-12-01
DOHERTY CATHERINE
SVP, Group Exec. Clin. Fran.
S - Sale
Common Stock
-37,565
$157.00
-5.90M
5
$20.07B
2021-10-01
2021-10-05
RING TIMOTHY
A - Grant
Phantom Stock Units
288
$144.00
41,472
1
$20.07B
2021-08-16
2021-08-17
DOI TRACEY
A - Grant
Common Stock
905
$0.00
1
$20.07B
2021-07-29
2021-07-30
RUSCKOWSKI STEPHEN
Chairman, CEO and President
S - Sale
Common Stock
-9,493
$141.00
-1.34M
2
$20.07B
2021-07-29
2021-07-30
RUSCKOWSKI STEPHEN
Chairman, CEO and President
M - Exercise
Non-Qualifed Stock Option (right to buy)
-9,493
$96.00
-911K
2
$20.07B
2021-07-29
2021-07-30
RUSCKOWSKI STEPHEN
Chairman, CEO and President
M - Exercise
Common Stock
9,493
$96.00
911K
2
$20.07B
2021-07-28
2021-07-30
RUSCKOWSKI STEPHEN
Chairman, CEO and President
M - Exercise
Common Stock
140K
$96.00
13M
1
$20.07B
2021-07-28
2021-07-30
RUSCKOWSKI STEPHEN
Chairman, CEO and President
S - Sale
Common Stock
-140K
$140.00
-20M
1
$20.07B
2021-07-28
2021-07-30
RUSCKOWSKI STEPHEN
Chairman, CEO and President
M - Exercise
Non-Qualifed Stock Option (right to buy)
-140K
$96.00
-13M
1
$20.07B
2021-07-27
2021-07-28
RUSCKOWSKI STEPHEN
Chairman, CEO and President
M - Exercise
Non-Qualifed Stock Option (right to buy)
-32,788
$96.00
-3.15M
1
$20.07B
2021-07-27
2021-07-28
RUSCKOWSKI STEPHEN
Chairman, CEO and President
M - Exercise
Common Stock
32,788
$96.00
3.15M
1
$20.07B
2021-07-27
2021-07-28
WILENSKY GAIL
M - Exercise
Stock Options (Right to Buy)
-12,222
$59.00
-721K
2
$20.07B
2021-07-27
2021-07-28
WILENSKY GAIL
M - Exercise
Common Stock
12,222
$59.00
721K
2
$20.07B
2021-07-27
2021-07-28
RUSCKOWSKI STEPHEN
Chairman, CEO and President
S - Sale
Common Stock
-32,788
$140.00
-4.59M
1
$20.07B
2021-07-27
2021-07-28
WILENSKY GAIL
S - Sale
Common Stock
-12,222
$139.00
-1.70M
2
$20.07B
2021-07-26
2021-07-28
RUSCKOWSKI STEPHEN
Chairman, CEO and President
S - Sale
Common Stock
-5,813
$140.00
-814K
1
$20.07B
2021-07-26
2021-07-28
RUSCKOWSKI STEPHEN
Chairman, CEO and President
M - Exercise
Non-Qualifed Stock Option (right to buy)
-5,813
$96.00
-558K
1
$20.07B
2021-07-26
2021-07-28
RUSCKOWSKI STEPHEN
Chairman, CEO and President
M - Exercise
Common Stock
5,813
$96.00
558K
1
$20.07B
2021-07-01
2021-07-06
RING TIMOTHY
A - Grant
Phantom Stock Units
313
$133.00
41,629
1
$20.07B
2021-05-25
2021-05-25
PFEIFFER GARY
A - Grant
Common Stock
1,363
$0.00
1
$20.07B
2021-05-25
2021-05-25
LASSITER WRIGHT III
A - Grant
Common Stock
1,363
$0.00
1
$20.07B
2021-05-25
2021-05-25
MAIN TIMOTHY
A - Grant
Common Stock
1,363
$0.00
1
$20.07B
2021-05-25
2021-05-25
MORRISON DENISE
A - Grant
Common Stock
1,363
$0.00
1
$20.07B
2021-05-25
2021-05-25
RING TIMOTHY
A - Grant
Common Stock
1,363
$0.00
1
$20.07B
2021-05-25
2021-05-25
TORLEY HELEN
A - Grant
Common Stock
1,363
$0.00
1
$20.07B
2021-05-25
2021-05-25
WILENSKY GAIL
A - Grant
Common Stock
1,363
$0.00
1
$20.07B
2021-05-21
2021-05-25
GREGG VICKY
A - Grant
Common Stock
1,363
$0.00
1
$20.07B
2021-05-18
2021-05-20
DEPPE MICHAEL
VP, Corp. Controller & CAO
F - Tax
Common Stock
-5
$137.00
-685
1
$20.07B
2021-05-07
2021-05-11
DOHERTY CATHERINE
SVP, Group Exec. Clin. Fran.
S - Sale
Common Stock
-8,536
$140.00
-1.20M
1
$20.07B
2021-05-05
2021-05-07
PREVOZNIK MICHAEL
SVP & General Counsel
M - Exercise
Non-Qualifed Stock Option (right to buy)
-44,939
$71.00
-3.19M
1
$20.07B
2021-05-05
2021-05-07
PREVOZNIK MICHAEL
SVP & General Counsel
S - Sale
Common Stock
-44,939
$137.00
-6.16M
1
$20.07B
2021-05-05
2021-05-07
PREVOZNIK MICHAEL
SVP & General Counsel
M - Exercise
Common Stock
44,939
$71.00
3.19M
1
$20.07B
2021-04-01
2021-04-02
RING TIMOTHY
A - Grant
Phantom Stock Units
325
$128.00
41,600
1
$20.07B
2021-03-10
2021-03-11
PREVOZNIK MICHAEL
SVP & General Counsel
S - Sale
Common Stock
-5,574
$120.00
-669K
1
$20.07B
2021-03-09
2021-03-11
RUSCKOWSKI STEPHEN
Chairman, CEO and President
A - Grant
Common Stock
58,368
$115.00
6.71M
1
$20.07B
2021-03-09
2021-03-11
DAVIS
EVP, General Diagnostics
F - Tax
Common Stock
-8,334
$115.00
-958K
1
$20.07B
2021-03-09
2021-03-11
DEPPE MICHAEL
VP, Corp. Controller & CAO
F - Tax
Common Stock
-684
$115.00
-78,660
1
$20.07B
2021-03-09
2021-03-11
GUINAN MARK
Executive Vice President & CFO
F - Tax
Common Stock
-6,403
$115.00
-736K
1
$20.07B
2021-03-09
2021-03-11
PREVOZNIK MICHAEL
SVP & General Counsel
F - Tax
Common Stock
-4,217
$115.00
-485K
1
$20.07B
2021-03-09
2021-03-11
RUSCKOWSKI STEPHEN
Chairman, CEO and President
F - Tax
Common Stock
-25,887
$115.00
-2.98M
1
$20.07B
2021-03-09
2021-03-11
DEPPE MICHAEL
VP, Corp. Controller & CAO
A - Grant
Common Stock
1,884
$115.00
217K
1
$20.07B
2021-03-09
2021-03-11
DOHERTY CATHERINE
SVP, Group Exec. Clin. Fran.
F - Tax
Common Stock
-5,066
$115.00
-583K
1
$20.07B
2021-03-09
2021-03-11
EGLINTON MANNER CARRIE
SVP, Advanced Diagnostics
F - Tax
Common Stock
-6,165
$115.00
-709K
1
$20.07B
2021-03-09
2021-03-11
DAVIS
EVP, General Diagnostics
A - Grant
Common Stock
16,570
$115.00
1.91M
1
$20.07B
2021-03-09
2021-03-11
DOHERTY CATHERINE
SVP, Group Exec. Clin. Fran.
A - Grant
Common Stock
11,299
$115.00
1.30M
1
$20.07B
2021-03-09
2021-03-11
EGLINTON MANNER CARRIE
SVP, Advanced Diagnostics
A - Grant
Common Stock
13,181
$115.00
1.52M
1
$20.07B
2021-03-09
2021-03-11
GUINAN MARK
Executive Vice President & CFO
A - Grant
Common Stock
17,322
$115.00
1.99M
1
$20.07B
2021-03-09
2021-03-11
PREVOZNIK MICHAEL
SVP & General Counsel
A - Grant
Common Stock
9,791
$115.00
1.13M
1
$20.07B
2021-02-25
2021-03-01
PREVOZNIK MICHAEL
SVP & General Counsel
S - Sale
Common Stock
-801
$115.00
-92,115
1
$20.07B
2021-02-24
2021-02-25
DEPPE MICHAEL
VP, Corp. Controller & CAO
F - Tax
Common Stock
-103
$121.00
-12,463
1
$20.07B
2021-02-24
2021-02-25
PREVOZNIK MICHAEL
SVP & General Counsel
F - Tax
Common Stock
-455
$121.00
-55,055
1
$20.07B
2021-02-24
2021-02-25
RUSCKOWSKI STEPHEN
Chairman, CEO and President
F - Tax
Common Stock
-3,319
$121.00
-402K
1
$20.07B
2021-02-24
2021-02-25
PREVOZNIK MICHAEL
SVP & General Counsel
S - Sale
Common Stock
-1,188
$117.00
-139K
2
$20.07B
2021-02-24
2021-02-25
GUINAN MARK
Executive Vice President & CFO
F - Tax
Common Stock
-541
$121.00
-65,461
1
$20.07B
2021-02-24
2021-02-25
EGLINTON MANNER CARRIE
SVP, Advanced Diagnostics
F - Tax
Common Stock
-611
$121.00
-73,931
1
$20.07B
2021-02-24
2021-02-25
DOHERTY CATHERINE
SVP, Group Exec. Clin. Fran.
F - Tax
Common Stock
-524
$121.00
-63,404
1
$20.07B
2021-02-24
2021-02-25
DAVIS
EVP, General Diagnostics
F - Tax
Common Stock
-806
$121.00
-97,526
1
$20.07B
2021-02-23
2021-02-25
DEPPE MICHAEL
VP, Corp. Controller & CAO
F - Tax
Common Stock
-159
$121.00
-19,239
1
$20.07B
2021-02-23
2021-02-25
EGLINTON MANNER CARRIE
SVP, Advanced Diagnostics
F - Tax
Common Stock
-1,017
$121.00
-123K
1
$20.07B
2021-02-23
2021-02-25
DAVIS
EVP, General Diagnostics
F - Tax
Common Stock
-1,250
$121.00
-151K
1
$20.07B
2021-02-23
2021-02-25
DOHERTY CATHERINE
SVP, Group Exec. Clin. Fran.
F - Tax
Common Stock
-796
$121.00
-96,316
1
$20.07B
2021-02-23
2021-02-25
GUINAN MARK
Executive Vice President & CFO
F - Tax
Common Stock
-830
$121.00
-100K
1
$20.07B
2021-02-23
2021-02-25
PREVOZNIK MICHAEL
SVP & General Counsel
F - Tax
Common Stock
-693
$121.00
-83,853
1
$20.07B
2021-02-23
2021-02-25
RUSCKOWSKI STEPHEN
Chairman, CEO and President
F - Tax
Common Stock
-4,033
$121.00
-488K
1
$20.07B
2021-02-17
2021-02-22
MENDEZ MANUEL
SVP & Chief Commercial Officer
A - Grant
Common Stock
4,926
$0.00
1
$20.07B
2021-02-17
2021-02-22
MENDEZ MANUEL
SVP & Chief Commercial Officer
A - Grant
Non-Qualifed Stock Option (right to buy)
27,633
$0.00
1
$20.07B
2021-02-17
2021-02-19
PREVOZNIK MICHAEL
SVP & General Counsel
A - Grant
Non-Qualifed Stock Option (right to buy)
17,958
$0.00
1
$20.07B
2021-02-17
2021-02-19
PREVOZNIK MICHAEL
SVP & General Counsel
A - Grant
Common Stock
3,202
$0.00
1
$20.07B
2021-02-17
2021-02-19
RUSCKOWSKI STEPHEN
Chairman, CEO and President
A - Grant
Non-Qualifed Stock Option (right to buy)
121K
$0.00
1
$20.07B
2021-02-17
2021-02-19
DAVIS
EVP, General Diagnostics
A - Grant
Non-Qualifed Stock Option (right to buy)
31,774
$0.00
1
$20.07B
2021-02-17
2021-02-19
DAVIS
EVP, General Diagnostics
A - Grant
Common Stock
5,665
$0.00
1
$20.07B
2021-02-17
2021-02-19
DEPPE MICHAEL
VP, Corp. Controller & CAO
A - Grant
Non-Qualifed Stock Option (right to buy)
4,003
$0.00
1
$20.07B
2021-02-17
2021-02-19
DEPPE MICHAEL
VP, Corp. Controller & CAO
A - Grant
Common Stock
715
$0.00
1
$20.07B
2021-02-17
2021-02-19
DOHERTY CATHERINE
SVP, Group Exec. Clin. Fran.
A - Grant
Non-Qualifed Stock Option (right to buy)
22,105
$0.00
1
$20.07B
2021-02-17
2021-02-19
DOHERTY CATHERINE
SVP, Group Exec. Clin. Fran.
A - Grant
Common Stock
3,941
$0.00
1
$20.07B
2021-02-17
2021-02-19
EGLINTON MANNER CARRIE
SVP, Advanced Diagnostics
A - Grant
Non-Qualifed Stock Option (right to buy)
27,633
$0.00
1
$20.07B
2021-02-17
2021-02-19
EGLINTON MANNER CARRIE
SVP, Advanced Diagnostics
A - Grant
Common Stock
4,926
$0.00
1
$20.07B
2021-02-17
2021-02-19
RUSCKOWSKI STEPHEN
Chairman, CEO and President
A - Grant
Common Stock
21,551
$0.00
1
$20.07B
2021-02-17
2021-02-19
GUINAN MARK
Executive Vice President & CFO
A - Grant
Non-Qualifed Stock Option (right to buy)
31,774
$0.00
1
$20.07B
2021-02-17
2021-02-19
GUINAN MARK
Executive Vice President & CFO
A - Grant
Common Stock
5,665
$0.00
1
$20.07B
2021-01-04
2021-01-07
RING TIMOTHY
A - Grant
Phantom Stock Units
264
$120.00
31,680
1
$20.07B
2021-01-04
2021-01-07
EGLINTON MANNER CARRIE
SVP, Advanced Diagnostics
F - Tax
Common Stock
-2,640
$119.00
-314K
1
$20.07B
2020-12-24
2020-12-28
GUINAN MARK
Executive Vice President & CFO
M - Exercise
Non-Qualifed Stock Option (right to buy)
-81,756
$67.00
-5.48M
1
$20.07B
2020-12-24
2020-12-28
GUINAN MARK
Executive Vice President & CFO
M - Exercise
Common Stock
81,756
$67.00
5.48M
1
$20.07B
2020-12-24
2020-12-28
GUINAN MARK
Executive Vice President & CFO
S - Sale
Common Stock
-81,756
$120.00
-9.81M
2
$20.07B
2020-11-24
2020-11-27
WILENSKY GAIL
S - Sale
Common Stock
-6,111
$126.00
-770K
1
$20.07B
2020-11-24
2020-11-27
WILENSKY GAIL
M - Exercise
Stock Options (Right to Buy)
-6,111
$58.00
-354K
1
$20.07B
2020-11-24
2020-11-27
WILENSKY GAIL
M - Exercise
Common Stock
6,111
$58.00
354K
1
$20.07B
2020-11-23
2020-11-24
STANZIONE DANIEL
S - Sale
Common Stock
-11,223
$126.00
-1.41M
3
$20.07B
2020-10-21
2020-10-23
DEPPE MICHAEL
VP, Corp. Controller & CAO
M - Exercise
Non-Qualifed Stock Option (right to buy)
-10,450
$57.00
-596K
2
$20.07B
2020-10-21
2020-10-23
DEPPE MICHAEL
VP, Corp. Controller & CAO
M - Exercise
Common Stock
10,450
$57.00
596K
2
$20.07B
2020-10-21
2020-10-23
DEPPE MICHAEL
VP, Corp. Controller & CAO
S - Sale
Common Stock
-10,450
$125.00
-1.31M
2
$20.07B
2020-10-16
2020-10-19
RUSCKOWSKI STEPHEN
Chairman, CEO and President
S - Sale
Common Stock
-292K
$120.00
-35M
1
$20.07B
2020-10-16
2020-10-19
RUSCKOWSKI STEPHEN
Chairman, CEO and President
M - Exercise
Non-Qualifed Stock Option (right to buy)
-292K
$67.00
-20M
1
$20.07B
2020-10-16
2020-10-19
RUSCKOWSKI STEPHEN
Chairman, CEO and President
M - Exercise
Common Stock
292K
$67.00
20M
1
$20.07B
2020-10-14
2020-10-15
PREVOZNIK MICHAEL
SVP & General Counsel
M - Exercise
Common Stock
35,591
$52.00
1.85M
1
$20.07B
2020-10-14
2020-10-15
PREVOZNIK MICHAEL
SVP & General Counsel
S - Sale
Common Stock
-35,591
$119.00
-4.24M
1
$20.07B
2020-10-14
2020-10-15
PREVOZNIK MICHAEL
SVP & General Counsel
M - Exercise
Stock Options (Right to Buy)
-35,591
$52.00
-1.85M
1
$20.07B
2020-10-06
2020-10-07
MENDEZ MANUEL
SVP & Chief Commercial Officer
F - Tax
Common Stock
-5,871
$114.00
-669K
1
$20.07B
2020-10-01
2020-10-05
RING TIMOTHY
A - Grant
Phantom Stock Units
270
$114.00
30,780
1
$20.07B
2020-09-02
2020-09-04
DOHERTY CATHERINE
SVP, Group Exec. Clin. Fran.
S - Sale
Common Stock
-58,392
$111.00
-6.48M
2
$20.07B
2020-09-02
2020-09-04
DOHERTY CATHERINE
SVP, Group Exec. Clin. Fran.
M - Exercise
Non-Qualifed Stock Option (right to buy)
-58,392
$67.00
-3.91M
1
$20.07B